Why it happens, according to the research
Antidepressants alter serotonin — and for some classes noradrenaline — signalling from the first dose. The receptor-level adaptation that produces the calming therapeutic effect takes longer to develop. Maudsley Prescribing Guidelines and RANZCP describe the early-anxiety phenomenon as a known feature of the medication class, which is partly why low starting doses with gradual titration are common practice — the goal is to give receptors time to adapt before the dose reaches therapeutic levels.
What it tends to feel like
Clinical resources from the Royal College of Psychiatrists and Beyond Blue describe the experience in similar terms across major patient-education resources:
A wired or restless quality, sometimes a racier heart rate, occasionally panic-like episodes. The body can feel activated or unsettled in a way that is distinct from the anxiety someone came to treat.
Sleep is often disrupted alongside the anxiety — difficulty falling asleep, lighter sleep, or earlier waking. The activating effect that produces the anxiety bump tends to affect sleep through the same mechanism.
Existing anxiety patterns can feel sharper — not a new anxiety, but an amplified version of familiar ones. This is described consistently across Royal College of Psychiatrists and NPS MedicineWise patient resources.
How long it usually lasts
Across NICE, RANZCP, and NPS MedicineWise resources, the early anxiety bump is described as typically resolving by the end of week two and well-settled by week three. By weeks four to six, the anti-anxiety effect of the medication is usually beginning to be felt for those who will respond. If anxiety has not settled by week three, this is a conversation to have with the prescriber — not a reason to stop silently.
What the evidence suggests can help
Consistent daily dose timing with food where tolerated. Endorsed by major prescribing resources for managing early side effects and reducing blood-level variability.
Reduced caffeine for the first two to three weeks. Caffeine sensitivity can be elevated when starting treatment, and caffeine can amplify the activating effect of the medication.
Reduced alcohol. Alcohol disrupts sleep and can interact unpredictably with antidepressants — the combination typically worsens both the anxiety and the sleep disruption.
Self-tracking. A short daily note on sleep, body, and mood over two weeks will usually show whether anxiety is settling or staying flat — giving you and your prescriber something concrete to work with.
Informed expectation-setting. Cochrane adherence reviews indicate that patients who know the early anxiety bump is a recognised pattern are less likely to stop the medication during it.
Telling someone close to you. Social support during this window correlates with better adherence in observational data — having someone who knows what you are going through matters.
When to call your prescriber sooner
- New suicidal thoughts — contact your prescriber or emergency services immediately
- Severe anxiety or panic that is not manageable — not just uncomfortable, but significantly impairing
- Anxiety that is increasing rather than holding flat by the end of week two
- Any new neurological symptoms — confusion, tremor, fever, or a racing heart that is not normal for you
The early anxiety bump is expected to plateau and ease — not escalate. If it is worsening rather than holding flat, that distinction matters and is worth raising at your earliest opportunity.
Frequently asked questions
Does the early anxiety bump happen with every antidepressant?+
It is more commonly documented with SSRIs and SNRIs, which are the most prescribed classes. Profiles vary across individual medications — Maudsley Prescribing Guidelines discuss comparative early-side-effect profiles in detail. The prescriber who chose your specific medication will have had this pattern in mind when recommending a starting dose.
Will the medication still work for anxiety if it makes anxiety worse at first?+
Yes — clinical experience and RANZCP guidance describe this as a recognised pattern. The early bump and the eventual anti-anxiety effect are different mechanisms operating on different timescales. Many people who respond well to an antidepressant for anxiety go through a difficult first two weeks before the benefit appears.
Should I have started at a lower dose?+
Low starting doses with gradual titration are common practice for exactly this reason — prescriber resources including NICE and Maudsley recommend it where appropriate. If the early anxiety is severe, a dose adjustment is a reasonable conversation to have at your follow-up appointment rather than something to manage alone.
Evidence and sources referenced
- NICE Guideline NG222 — Depression in adults: treatment and management
- RANZCP — Clinical Practice Guidelines for Mood Disorders
- NPS MedicineWise — patient resources on early antidepressant side effects (Australia)
- TGA and FDA product information — listed early adverse effects for SSRI and SNRI classes
- Beyond Blue — patient information on antidepressant treatment
- Maudsley Prescribing Guidelines in Psychiatry — early-side-effect management and titration
- Cochrane Library — adherence and informed-consent reviews
Related articles
Want to track whether the anxiety is settling or worsening?
Causiq is being built to help you track the first 90 days simply — so you walk into your next appointment with a clear picture of what actually happened.
Join the waitlist →